No abstract available
Keywords:
Benlysta; Cellcept; Cytoxan; Imuran; Metoject; Plaquenil; Procytox; Rheumatrex; Rituxan; Saphnelo; adverse effects; anifrolumab; azathioprine; belimumab; corticosteroids; cyclophosphamide; dosage; efficacy; hydroxychloroquine; lactation; lupus; methotrexate; mycophenolate mofetil; pregnancy; rituximab; safety.
MeSH terms
-
Adrenal Cortex Hormones / administration & dosage
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Double-Blind Method
-
Drug Approval
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use*
-
Lupus Erythematosus, Systemic / drug therapy*
-
Randomized Controlled Trials as Topic
-
Severity of Illness Index
-
United States
-
United States Food and Drug Administration
Substances
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal, Humanized
-
Immunosuppressive Agents
-
anifrolumab